Bank of America
AYTU icon

Bank of America’s AYTU BioPharma AYTU Stock Holding History

Bank of America’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-85
Closed -$221 – 5794
2025
Q4 		$221 Buy
85
+11
+15% +$25 ﹤0.01% 6681
2025
Q3 		$139 Buy
74
+11
+17% +$25 ﹤0.01% 7790
2025
Q2 		$137 Sell
63
-40
-39% -$62 ﹤0.01% 7915
2025
Q1 		$124 Buy
103
+3
+3% +$4 ﹤0.01% 7792
2024
Q4 		$170 Buy
100
+2
+2% +$4 ﹤0.01% 7624
2024
Q3 		$231 Buy
98
+6
+7% +$16 ﹤0.01% 7534
2024
Q2 		$269 Buy
92
+42
+84% +$127 ﹤0.01% 7491
2024
Q1 		$152 Buy
+50
New +$143 ﹤0.01% 7366
2023
Q1 		– Sell
-67
Closed -$252 – 7801
2022
Q4 		$252 Buy
67
+12
+22% +$45 ﹤0.01% 7510
2022
Q3 		$0 Sell
55
-5
-8% -$38 ﹤0.01% 7822
2022
Q2 		$1K Hold
60
– – ﹤0.01% 7846
2022
Q1 		$1K Hold
60
– – ﹤0.01% 8090
2021
Q4 		$2K Sell
60
-276
-82% -$11.9K ﹤0.01% 7978
2021
Q3 		$19K Sell
336
-891
-73% -$66.9K ﹤0.01% 7396
2021
Q2 		$123K Sell
1,227
-1,558
-56% -$183K ﹤0.01% 6401
2021
Q1 		$424K Buy
2,785
+2,737
+5,702% +$434K ﹤0.01% 5510
2020
Q4 		$6K Buy
48
+28
+140% +$5.1K ﹤0.01% 6798
2020
Q3 		$4K Sell
20
-1,267
-98% -$326K ﹤0.01% 6611
2020
Q2 		$365K Buy
1,287
+887
+222% +$269K ﹤0.01% 4847
2020
Q1 		$120K Buy
+400
New +$77.2K ﹤0.01% 5409
2019
Q4 		– Hold
0
– – – 7077
2019
Q3 		– Sell
-147
Closed -$44.3K – 7249
2019
Q2 		$56K Buy
+147
New +$56K ﹤0.01% 6260
2019
Q1 		– Hold
0
– – – 7092
2018
Q4 		– Sell
-1
Closed -$220 – 7100
2018
Q3 		$0 Buy
+1
New +$926 ﹤0.01% 7257

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's AYTU Position: Q1 2026 in Review

Bank of America sold out of AYTU BioPharma (AYTU) in Q1 2026, closing a stake of 85 shares — an estimated $221 sold.

Bank of America first reported a position in AYTU in Q3 2018 and held it in 22 quarters. The position peaked at $424K in Q1 2021. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Bank of America reported no remaining AYTU BioPharma position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 85 AYTU BioPharma shares in Q1 2026, an estimated $221.
  • Bank of America first reported a position in AYTU BioPharma in Q3 2018 and held it in 22 quarters.
  • Bank of America's AYTU BioPharma position peaked at $424K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.